Document is current
Any future updates will be listed below
-
Authors
Kabiri, Maryam
Kamal, Syed H.
Pawar, Sandip V.
Roy, Protiva R.
Derakhshandeh, Maziar
Kumar, Ujendra
Hatzikiriakos, Savvas G.
Hossain, Sazzad
Yadav, Vikramaditya G.
-
Funding
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada
Mitacs
Canada Foundation of Innovation
- License Information
-
More Information
Article History
First Online: 5 March 2018
Compliance with ethical standards
:
: Sazzad Hossain is the Chief Scientific Officer of InMed Pharmaceuticals Inc., a biopharmaceutical company that is commercializing an anti-glaucoma treatment that employs the formulation described in this study.
